A clinically relevant dose of CoQ10 reversed liver fibrosis via downregulation of ROS, inflammation, and hyperinsulinemia and upregulation of the Nrf2/ARE antioxidant pathway. This evidence concerns the gene NFE2L2 and Hepatic fibrosis.